To Be Discontinued Tablet Neurology
Frovatriptan Succinate Table · 199 days since initial FDA posting
FDA lists Frovatriptan Succinate Table as To Be Discontinued (Endo Pharmaceuticals, Inc.).
No availability text on this FDA row.
Frovatriptan Succinate Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Frovatriptan Succinate Tablet
- Manufacturer
- Endo Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Presentation
- Frova, Tablet, 2.5 mg (NDC 63481-025-09)
- Package NDC
- 63481-025-09
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Feb 24, 2026
- Last Updated
- Feb 24, 2026
- Therapeutic Category
- Neurology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
A business decision was made to discontinue manufacture of the drug.
Nearby, Other Frovatriptan Shortage Records
FDA reason on file: A business decision was made to discontinue manufacture of the drug. General shortage guidance lives on the tracker hub.